Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Buy
27,070
+703
+3% +$81.2K 0.23% 100
2025
Q4
$2.78M Buy
26,367
+18,421
+232% +$1.73M 0.2% 112
2025
Q3
$667K Buy
7,946
+806
+11% +$66.4K 0.05% 232
2025
Q2
$565K Buy
7,140
+4,080
+133% +$324K 0.05% 250
2025
Q1
$275K Sell
3,060
-94
-3% -$8.78K 0.03% 331
2024
Q4
$314K Buy
3,154
+325
+11% +$33.5K 0.03% 290
2024
Q3
$321K Sell
2,829
-320
-10% -$38K 0.04% 292
2024
Q2
$390K Sell
3,149
-63
-2% -$8.12K 0.05% 255
2024
Q1
$424K Sell
3,212
-792
-20% -$97.6K 0.05% 241
2023
Q4
$436K Buy
+4,004
New +$416K 0.07% 230
2023
Q3
Sell
-1,779
Closed -$205K 218
2023
Q2
$205K Sell
1,779
-203
-10% -$23K 0.06% 193
2023
Q1
$211K Buy
+1,982
New +$214K 0.07% 181
2020
Q1
$446K Buy
+6,069
New +$477K 0.32% 76

Other funds holding MRK

Waterloo Capital's MRK Position: Q1 2026 in Review

Waterloo Capital increased its Merck (MRK) stake by 2.7% in Q1 2026, buying an estimated $81.2K and bringing the position to 27,070 shares worth $3.26M. The position accounts for 0.23% of the portfolio, ranked #100.

Waterloo Capital first reported a position in MRK in Q1 2020 and has held it in 13 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Waterloo Capital held 27,070 shares of Merck worth $3.26M as of Q1 2026.
  • Waterloo Capital bought 703 Merck shares in Q1 2026, an estimated $81.2K.
  • Merck made up 0.23% of Waterloo Capital's portfolio in Q1 2026, its #100 holding.
  • Waterloo Capital first reported a position in Merck in Q1 2020 and has held it in 13 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.